Shah Nikita
Executive Vice President · 17 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 17,976 | $13.30 | $239,080.80 | filing |
| 2026-03-04 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 35,880 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 183,853 | $13.31 | $2.4M | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 22,982 | $13.31 | $305,890.42 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 18,502 | $13.31 | $246,261.62 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Tax withholding | 11,796 | $13.31 | $157,004.76 | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 366,972 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 36,232 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 45,871 | — | — | filing |
| 2026-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 23,544 | — | — | filing |
| 2025-11-12 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 131,856 | $11.92 | $1.6M | filing |
| 2025-11-12 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 95,525 | $2.75 | $262,693.75 | filing |
| 2025-11-12 | AMRX | Amneal Pharmaceuticals, Inc. | Option exercise | 36,331 | $2.75 | $99,910.25 | filing |
| 2025-08-25 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 6,340 | $9.50 | $60,230.00 | filing |
| 2025-08-22 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 114,492 | $9.66 | $1.1M | filing |
| 2025-08-14 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 71,694 | $9.29 | $666,037.26 | filing |
| 2025-08-12 | AMRX | Amneal Pharmaceuticals, Inc. | Sale | 50,000 | $9.04 | $452,000.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.